Research

News on Science, Technology and Research in India

India’s R&D Expenditure & Scientific Publications on the Rise

India’s gross expenditure in R&D has tripled between 2008 & 2018 driven mainly by Govt sector and scientific publications have risen placing the country internationally among the top few. This is as per the R&D Statistics and Indicators 2019-20 based on the national S&T survey 2018 brought out by the National Science and Technology Management Information (NSTMIS), Department of Science and Technology (DST).

Microwave Steriliser to Disintegrate Covid-19 Developed

Defence Institute of Advanced Technology, Pune, a deemed university supported by Defence Research and Development Organisation has developed a microwave steriliser named as ‘ATULYA’ to disintegrate (COVID-19). The virus gets disintegrated by differential heating in the range of 560 to 600 Celsius temperatures.

Indian Scientists Develop a Natural Product Based Alzheimer Inhibitor

Scientists from Jawaharlal Nehru Centre For Advanced Scientific Research (JNCASR) an autonomous institute under the Department of Science & Technology (DST), Govt. of India have modified the structure of Berberine, a natural and cheap product similar to curcumin, available commercially, into Ber-D to use as a Alzheimer’s inhibitor. Their research work has been published in the scientific journal iSceince.

Indian Researchers Make Herbal Decongestant Spray

Health authorities have been strongly advocating the use of face masks to prevent corona infection. At the same time, wearinga mask for a long time is reportedly causing difficulties in breathing and congestion in the respiratory system. To address this issue, scientists at CSIR-National Botanical Research Institute (NBRI), Lucknow, have developed a herbal decongestant spray.

Indian Researchers To Go for Clinical Trial of Sepsis Drug Against Covid-19

The drug contains heat-killed Mycobacterium W (Mw). It is found to be safe in patients and no systemic side effects are associated with its use. It can be used concurrently with any other therapies required in the management of such critically ill patients without any restriction. Its unique properties include boosting protective immunity (Th1, TLR2 agonist) and suppressing non-protective response (Th2).